Compare

Corvus Pharmaceuticals, Inc. vs Werewolf Therapeutics, Inc. vs Incannex Healthcare Inc. vs Context Therapeutics Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearCorvus Pharmaceuticals, Inc.
CRVS
Werewolf Therapeutics, Inc.
HOWL
Incannex Healthcare Inc.
IXHL
Context Therapeutics Inc.
CNTX
Year ended2025-12-312025-12-312026-06-302025-12-31
Revenuen/an/a$0n/a
Revenue growth (YoY)n/an/a-100.0%n/a
Gross marginn/an/an/an/a
Operating marginn/an/an/an/a
Net marginn/an/an/an/a
Net income-$15.28M-$60.82M-$19.30M-$36.12M
EPS (Diluted)-$0.53-$1.33-$1.66-$0.38
Operating cash flow-$32.80M-$60.29M-$12.87M-$26.39M
Free cash flow-$32.97M-$60.29M-$12.88M-$26.42M
Cash & equivalents$4.58M$57.05M$67.71M$66.00M
Total assets$71.12M$69.40M$72.98M$68.49M
Total liabilities$9.91M$44.59M$5.61M$8.02M
Shareholders' equity$61.20M$24.80M$67.37M$60.47M
Return on year-end equity-25.0%-245.2%-28.6%-59.7%
Shares outstanding74.70M48.60M12.54M91.88M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearCorvus Pharmaceuticals, Inc.Werewolf Therapeutics, Inc.Incannex Healthcare Inc.Context Therapeutics Inc.
Latestn/an/a$0
Ended 2026-06-30
n/a
1 year earliern/an/a$86.0K
Ended 2025-06-30
n/a
2 years earliern/an/a$12.0K
Ended 2024-06-30
n/a
3 years earliern/an/an/an/a
4 years earliern/an/an/an/a